COMMUNIQUÉ RÉGLEMENTÉ
News
-
-
-
COMMUNIQUÉ DE PRESSE
BNP PARIBAS LANCE SON PROGRAMME DE RACHAT D’ACTIONS AU TITRE DE L’EXERCICE 2025 D’UN MONTANT DE 1,15 MILLIARD D’EUROS
BNP PARIBAS lance son programme de rachat d'actions au titre de l'exercice 2025 d'un montant de 1,15 milliard d'euros, conformément aux dispositions légales en vigueur -
COMMUNIQUÉ DE PRESSE
BNP PARIBAS LAUNCHES A SHARE BUYBACK PROGRAMME OF EUR 1.15 BILLION FOR THE 2025 FINANCIAL YEAR RESULTS
BNP Paribas launches a share buyback program of EUR 1.15 billion for the 2025 financial year results. The program follows approval from the European Central Bank, aims to repurchase shares for various purposes as outlined in the press release -
COMMUNIQUÉ DE PRESSE
Medartis appoints Peter Hackel as new Chief Financial Officer
Medartis appoints Peter Hackel as new Chief Financial Officer effective 1 January 2026. Dr Dirk Kirsten, current CFO, to conclude service after transition. Hackel has strong financial leadership experience in growth-oriented companies -
-
-
-
COMMUNIQUÉ DE PRESSE
Hans-Joachim Watzke resigns as managing director of Borussia Dortmund Geschäftsführungs-GmbH and is elected president of Ballspielverein Borussia 09 e.V. Dortmund
Hans-Joachim Watzke resigns as managing director of Borussia Dortmund Geschäftsführungs-GmbH and is elected president of Ballspielverein Borussia 09 e.V. Dortmund -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Bayer Aktiengesellschaft: Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention
Bayer announces positive results from Phase III OCEANIC-STROKE study, showing asundexian reduces ischemic stroke risk with antiplatelet therapy
